Search research articles
Contact Us
Filters
Showing results (111-120 of 168) with videos related to
Page
of 17
Sort By:
International Journal of Cancer
|
July 21, 2007
Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia
Michael S Wiesener, Philine Münchenhagen, Markus Gläser, et al.
Cancer Research
|
May 23, 2002
Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation
Kevin J Turner, John W Moore, Adam Jones, et al.
Cancer Cell
|
July 19, 2002
HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron
Stefano J Mandriota, Kevin J Turner, David R Davies, et al.
Nature Communications
|
November 26, 2014
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
Anne-Theres Henze, Boyan K Garvalov, Sascha Seidel, et al.
The Journal of Pediatrics
|
May 14, 2016
Dent Disease in Chinese Children and Findings from Heterozygous Mothers: Phenotypic Heterogeneity, Fetal Growth, and 10 Novel Mutations
Fucheng Li, Zhihui Yue, Tingting Xu, et al.
Journal of the American Society of Nephrology : JASN
|
June 24, 2004
Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3' untranslated region of the Megsin gene
You-Ji Li, Yong Du, Cai-Xia Li, et al.
Cardiovascular Research
|
July 28, 2014
HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore
Sang-Ging Ong, Won Hee Lee, Louise Theodorou, et al.
Haematologica
|
October 17, 2009
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin
Damien R Ashby, Daniel P Gale, Mark Busbridge, et al.
Lancet (London, England)
|
October 12, 2016
Manifesto for a healthy and health-creating society
Nigel Crisp, David Stuckler, Richard Horton, et al.
Kidney International
|
February 13, 2009
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
Damien R Ashby, Daniel P Gale, Mark Busbridge, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 168) with videos related to
Sort By:
Page
of 17
International Journal of Cancer
|
July 21, 2007
Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia
Michael S Wiesener, Philine Münchenhagen, Markus Gläser, et al.
Cancer Research
|
May 23, 2002
Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation
Kevin J Turner, John W Moore, Adam Jones, et al.
Cancer Cell
|
July 19, 2002
HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron
Stefano J Mandriota, Kevin J Turner, David R Davies, et al.
Nature Communications
|
November 26, 2014
Loss of PHD3 allows tumours to overcome hypoxic growth inhibition and sustain proliferation through EGFR
Anne-Theres Henze, Boyan K Garvalov, Sascha Seidel, et al.
The Journal of Pediatrics
|
May 14, 2016
Dent Disease in Chinese Children and Findings from Heterozygous Mothers: Phenotypic Heterogeneity, Fetal Growth, and 10 Novel Mutations
Fucheng Li, Zhihui Yue, Tingting Xu, et al.
Journal of the American Society of Nephrology : JASN
|
June 24, 2004
Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3' untranslated region of the Megsin gene
You-Ji Li, Yong Du, Cai-Xia Li, et al.
Cardiovascular Research
|
July 28, 2014
HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore
Sang-Ging Ong, Won Hee Lee, Louise Theodorou, et al.
Haematologica
|
October 17, 2009
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin
Damien R Ashby, Daniel P Gale, Mark Busbridge, et al.
Lancet (London, England)
|
October 12, 2016
Manifesto for a healthy and health-creating society
Nigel Crisp, David Stuckler, Richard Horton, et al.
Kidney International
|
February 13, 2009
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
Damien R Ashby, Daniel P Gale, Mark Busbridge, et al.
Page
of 17